Yaxin Li

Engineering Novel VPAC2-Selective Agonists with Improved Stability and Glucose-Lowering Activity in Vivo

C. Pan, Y. J. Wang, T. Claus, 2007, Journal of Pharmacology and Experimental Therapeutics.

A potent and highly selective VPAC2 agonist enhances glucose-induced insulin release and glucose disposal: a potential therapy for type 2 diabetes.

C. Pan, J. Livingston, T. Claus, 2002, Diabetes.

Small-molecule ghrelin receptor antagonists improve glucose tolerance, suppress appetite, and promote weight loss.

J. Livingston, S. Gardell, T. Claus, 2007, Endocrinology.

PDE-10A inhibitors as insulin secretagogues.

Lei Zhu, J. Livingston, T. Claus, 2007, Bioorganic & medicinal chemistry letters.